Arax Advisory Partners’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.8M Sell
421,050
-5,375
-1% -$277K 0.12% 180
2026
Q2
$22.2M Buy
+426,425
New +$20.4M 0.15% 146

Other funds holding CPAI

Arax Advisory Partners's CPAI Position: Q3 2026 in Review

Arax Advisory Partners reduced its Counterpoint Quantitative Equity ETF (CPAI) stake by 1.3% in Q3 2026, selling an estimated $277K and leaving 421,050 shares worth $21.8M. The position accounts for 0.12% of the portfolio, ranked #180.

Arax Advisory Partners first reported a position in CPAI in Q2 2026 and has held it in 2 quarters since. The position peaked at $22.2M in Q2 2026. 54 funds tracked by Wall St. Rank hold CPAI as of Q3 2026.

  • Arax Advisory Partners held 421,050 shares of Counterpoint Quantitative Equity ETF worth $21.8M as of Q3 2026.
  • Arax Advisory Partners sold 5,375 Counterpoint Quantitative Equity ETF shares in Q3 2026, an estimated $277K.
  • Counterpoint Quantitative Equity ETF made up 0.12% of Arax Advisory Partners's portfolio in Q3 2026, its #180 holding.
  • Arax Advisory Partners first reported a position in Counterpoint Quantitative Equity ETF in Q2 2026 and has held it in 2 quarters since.
  • Arax Advisory Partners's Counterpoint Quantitative Equity ETF position peaked at $22.2M in Q2 2026.
  • 54 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.